Careers
Contact Us
Healthcare Professionals
About Us
Management Team
Board of Directors
Scientific Advisory Board
Our Product
Our Science
Publications and Presentations
Clinical Trials – LOCK-IT 100
Learn More About CRBSIs
Visit CRBSIs.com
Investors
Investors
Press Releases
In the News
Presentations and Events
Investor FAQ
Analyst Coverage
Corporate Governance
SEC Filings
Healthcare Professionals
Careers
Contact Us
Home
>
Investors & Media
Press Releases
Review corporate releases related to governance, investor news, and other important announcements.
All
2026
2025
2024
2023
2022
2021
2020
2019
2018
Jan 09, 2026
CORMEDIX THERAPEUTICS TO PRESENT AT THE 44TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
Read more
Jan 08, 2026
CORMEDIX THERAPEUTICS ANNOUNCES PRELIMINARY FOURTH QUARTER AND FULL YEAR 2025 RESULTS AND PROVIDES BUSINESS UPDATES
Read more
CORMEDIX THERAPEUTICS ANNOUNCES LEADERSHIP AND BOARD UPDATES
Read more
Dec 18, 2025
CORMEDIX THERAPEUTICS ANNOUNCES POSITIVE DATA FROM ONGOING REAL WORLD EVIDENCE STUDY OF DEFENCATH
Read more
Nov 12, 2025
CORMEDIX INC. REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS AND UPDATES FY 2025 GUIDANCE
Read more
Oct 31, 2025
CORMEDIX INC. TO REPORT THIRD QUARTER 2025 FINANCIAL RESULTS AND PROVIDE A CORPORATE UPDATE ON NOVEMBER 12, 2025
Read more
Oct 23, 2025
CORMEDIX INC. RECEIVES INNOVATIVE TECHNOLOGY DESIGNATION FROM VIZIENT FOR DEFENCATH
Read more
Oct 20, 2025
CORMEDIX INC. ANNOUNCES PRELIMINARY THIRD QUARTER 2025 RESULTS AND RAISES 2025 NET REVENUE GUIDANCE
Read more
Sep 29, 2025
CORMEDIX ANNOUNCES COMPLETION OF ENROLLMENT IN PHASE III RESPECT CLINICAL TRIAL FOR REZZAYO
Read more
Sep 08, 2025
CORMEDIX ANNOUNCES STRATEGIC MINORITY INVESTMENT IN TALPHERA
Read more
See more
You have clicked on an external link and will be taken offsite.
Would you like to proceed?
CONTINUE
Cancel